Biotechnology Blueprint Medicines Receives Positive CHMP Opinion for Avapritinib for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors July 24, 2020
Biotechnology BioMarin Submits Marketing Authorization Application to European Medicines Agency for Vosoritide to Treat Children with Achondroplasia July 23, 2020
Biotechnology Editas Medicine to Host Conference Call Discussing Second Quarter 2020 Results and Corporate Update July 23, 2020
Health Biotech Stock Roundup: BIIB Reports Q2, GILD Acquires Stake in Private Company & More July 23, 2020
Search
